[go: up one dir, main page]

BRPI0417182A - composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica - Google Patents

composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica

Info

Publication number
BRPI0417182A
BRPI0417182A BRPI0417182-9A BRPI0417182A BRPI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A BR PI0417182 A BRPI0417182 A BR PI0417182A
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
salts
diastereoisomers
compound
pharmaceutical composition
Prior art date
Application number
BRPI0417182-9A
Other languages
English (en)
Inventor
Piero Del Soldato
Francesca Benedini
Ennio Ongini
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of BRPI0417182A publication Critical patent/BRPI0417182A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

"COMPOSTO E/OU OS ENANTIÈMEROS , DIASTEREOISÈMEROS E SAIS FARMACEUTICAMENTE ACEITáVEIS DO MESMO, USO DO MESMO, E, COMPOSIçãO FARMACêUTICA". A presente invenção refere-se aos nitro-óxi-derivados de bloqueadores adrenérgicos-<225> de fórmula geral (I): A-(Y-ONO~ 2~)~ 5~ e aos enantiómeros e diastereoisómeros e sais farmaceuticamente aceitáveis dos mesmo, às composições farmacêuticas contendo-os e ao uso deles para o tratamento de hipertensão, doenças cardiovasculares, glaucoma, dor de cabeça enxaqueca e doenças vasculares.
BRPI0417182-9A 2003-12-02 2004-12-01 composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica BRPI0417182A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104485 2003-12-02
PCT/EP2004/013682 WO2005054218A1 (en) 2003-12-02 2004-12-01 Nitrooxyderivatives of antihypertensive drugs

Publications (1)

Publication Number Publication Date
BRPI0417182A true BRPI0417182A (pt) 2007-03-06

Family

ID=34639310

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417182-9A BRPI0417182A (pt) 2003-12-02 2004-12-01 composto e/ou os enantiÈmeros, diastereoisÈmeros e sais farmaceuticamente aceitáveis do mesmo, uso do mesmo, e, composição farmacêutica

Country Status (21)

Country Link
US (1) US20070060586A1 (pt)
EP (1) EP1748994B1 (pt)
JP (1) JP2007513113A (pt)
KR (1) KR20060120164A (pt)
CN (1) CN1906182A (pt)
AP (1) AP2006003622A0 (pt)
AR (1) AR047264A1 (pt)
AT (1) ATE423107T1 (pt)
AU (1) AU2004295105A1 (pt)
BR (1) BRPI0417182A (pt)
CA (1) CA2548127A1 (pt)
DE (1) DE602004019579D1 (pt)
EA (1) EA200600891A1 (pt)
EC (1) ECSP066590A (pt)
ES (1) ES2320002T3 (pt)
IL (1) IL176061A0 (pt)
MA (1) MA28224A1 (pt)
NO (1) NO20062527L (pt)
TN (1) TNSN06151A1 (pt)
WO (1) WO2005054218A1 (pt)
ZA (1) ZA200604463B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
US7799784B2 (en) 2006-02-06 2010-09-21 Nicox S.A. Quinoxaline derivatives of alpha-2 adrenergic agonists
WO2007090733A1 (en) * 2006-02-06 2007-08-16 Nicox S.A. Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
US20230131943A1 (en) 2020-03-24 2023-04-27 Burnet Micheal W Anti-infective and anti-viral compounds and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
IT1295694B1 (it) * 1996-11-14 1999-05-27 Nicox Sa Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
IT1311923B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1314184B1 (it) * 1999-08-12 2002-12-06 Nicox Sa Composizioni farmaceutiche per la terapia di condizioni di stressossidativo

Also Published As

Publication number Publication date
KR20060120164A (ko) 2006-11-24
AU2004295105A1 (en) 2005-06-16
NO20062527L (no) 2006-06-30
EA200600891A1 (ru) 2006-10-27
US20070060586A1 (en) 2007-03-15
AP2006003622A0 (en) 2006-06-30
ES2320002T3 (es) 2009-05-18
EP1748994B1 (en) 2009-02-18
IL176061A0 (en) 2006-10-05
CN1906182A (zh) 2007-01-31
MA28224A1 (fr) 2006-10-02
CA2548127A1 (en) 2005-06-16
ATE423107T1 (de) 2009-03-15
ECSP066590A (es) 2006-10-17
ZA200604463B (en) 2007-04-25
EP1748994A1 (en) 2007-02-07
TNSN06151A1 (en) 2007-11-15
DE602004019579D1 (de) 2009-04-02
WO2005054218A1 (en) 2005-06-16
JP2007513113A (ja) 2007-05-24
AR047264A1 (es) 2006-01-11

Similar Documents

Publication Publication Date Title
SE0302760D0 (sv) New compounds
BRPI0418102A (pt) derivados de quinolina
BR0212378A (pt) Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio
BRPI0409227B8 (pt) &#34;composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)&#34;
BRPI0308495B8 (pt) composto piridinoila útil para a ativação de receptores 5-ht1f, formulação farmacêutica, e, uso de um composto
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
NO20033181L (no) Substituerte alkylaminderivater og fremgangsmåter for anvendelse
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
BR0316081A (pt) Derivados de 2-piridona como inibidores de elastase de neutrófilo
BRPI0418245B8 (pt) composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
BRPI0715579A2 (pt) &#34;composto, composição farmacêutica e uso de um composto&#34;
DE60130771D1 (de) Substituierte heterocyclische amide
BRPI0601282A (pt) composição, e método de modificar a formação de hidrato de gás
BR0108893B1 (pt) composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos.
BRPI0415759A (pt) compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
SE0401971D0 (sv) Piperidne derivatives
BR0210538A (pt) Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7
BRPI0507495A (pt) composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5
BR0315143A (pt) Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto
BRPI0409110A (pt) derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
BRPI0508107A (pt) derivados de indazol e composições farmacêuticas contendo os mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.